Quidel Corporation develops, manufactures, and markets point-of-care (POC) diagnostic solutions for infectious diseases and reproductive health primarily in the United States. It provides POC and other diagnostic tests under QuickVue, QuickVue+, QuickVue Advance, RapidVue, and Metra brand names. The company offers POC diagnostics products for infectious diseases, such as Influenza, Group A Strep, and Mononucleosis, as well as for reproductive health, which include pregnancy, Chlamydia, and Bacterial Vaginosis. In the oncology/gastrointestinal area, Quidel offers Immunoassay fecal occult blood test, an immunochemical diagnostic tool to detect the presence of blood in stool specimens; and a...